Feitian Moutai raises price; Morgan Stanley expects it to lift Moutai earnings and provide short-term support to wholesale prices

Overview

This report focuses on the price increase event for Kweichow Moutai Company Ltd.'s core product Feitian Moutai at 53%vol. The company announced that Feitian Moutai prices would rise from 31 March 2026, with a new ex-factory price for distributor channels of Rmb1,269/bottle and a direct-channel price of Rmb1,539/bottle. Morgan Stanley believes the increase reflects management's assessment of true demand for Feitian Moutai, especially based on demand observation after deployment on the iMoutai platform, and that it will make a positive contribution to profitability.

Core views

The key views are: first, the Feitian Moutai price increase should be EPS-accretive for Kweichow Moutai Company Ltd.; second, the hike together with a higher direct-sales share, reform of distributor fee structure for non-Feitian premium SKUs, and reductions in Moutai 1935 and non-Feitian premium SKU prices constitute a more market-oriented pricing action by the company this year; third, wholesale prices may rebound in the short term, but ultimately remain determined by supply and demand; fourth, higher Feitian Moutai prices can provide some cushion against possible volume declines of non-Feitian Moutai SKUs.

Analysis framework

The report is mainly event-driven fundamental analysis, evaluating the impact of the price hike by combining changes in pricing architecture, channel structure adjustment, wholesale price trends, and EPS sensitivity; valuation uses a base-case DCF methodology and references earnings forecasts and market data within the Morgan Stanley ModelWare framework.

Methodology notes

• Valuation methodsdiscounted cash flow methodology

  DCF valuation

  The base case uses the discounted cash flow method, with key assumptions including 11% WACC, 3% risk-free rate, 9.8% risk premium, and 2% long-term growth rate.

• earnings_impacteps accretion estimate

  Calculation of price-hike EPS contribution

  The report estimates that the Feitian Moutai price hike can contribute about 3-4% to 2026-27 EPS, assuming no further changes in volume.

• pricing_analysischannel price comparison

  Channel price and wholesale price analysis

  By comparing distributor ex-factory prices, direct-channel prices, wholesale prices, and retail price trends, the report assesses the impact of the hike on short-term wholesale pricing and long-term supply-demand balance.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Kweichow Moutai Company Ltd. (600519.SS, 600519 CG)

  The core covered name; the Feitian Moutai price increase directly affects earnings and valuation expectations.

  Strengths

  Strong brand power and pricing power in the core product; high earnings visibility supports valuation; the increase is expected to be EPS-accretive.

  Weaknesses

  Wholesale prices had previously fallen from a high level; demand and channel inventories still need monitoring; non-Feitian SKUs face sales adjustment pressure.

  Comparison

  Relative to other stocks in coverage, the report assigns Overweight, which implies expected risk-adjusted total return over the next 12-18 months should be above the coverage universe average.

  Risks

  Premium baijiu consumption recovers slower than expected, wholesale and retail prices continue to fall, and series-liquor performance remains weaker than expected.

• Feitian Moutai

  The core product and direct object of this event.

  Strengths

  It has scarce brand assets and high channel attention, and the pricing power still reflects a true demand assessment.

  Weaknesses

  Wholesale prices remain supply-demand constrained after any short-term rebound.

  Comparison

  Compared with Moutai 1935 and non-Feitian premium SKUs, this Feitian Moutai price move is an increase, while some non-Feitian SKUs were previously reduced with distributor fee reforms.

  Risks

  If end-customer demand is insufficient, the price increase may fail to sustain wholesale-price support.

Key data

• New distributor-channel ex-factory priceRmb1,269/bottlePreviously Rmb1,169/bottle, up Rmb100/bottle.
• New direct-channel priceRmb1,539/bottlePreviously Rmb1,499/bottle, up Rmb40/bottle.
• Estimated EPS contributionabout 3-4%For 2026-27, assuming no further volume changes.
• RatingOverweightMorgan Stanley equity rating.
• Target priceRmb1,790.00Corresponds to 26% upside from target price.
• Current priceRmb1,420.00Close on 30 Mar 2026.
• Market capitalizationRmb1,783,801 millionCurrent market cap disclosed in the chart.
• Enterprise valueRmb1,627,874 millionCurrent enterprise value disclosed in the chart.
• DCF key assumptions11% WACC; 2% long-term growth rateWACC components include 3% risk-free rate and 9.8% risk premium.

Impact & implications

The pricing move has a generally positive investment implication: it directly lifts Feitian Moutai per-bottle revenue and earnings sensitivity, and may improve short-term wholesale price expectations; in addition, it indicates that the company is applying more market-driven adjustments across demand, channels, and product mix. However, the report also warns that the persistence of wholesale prices ultimately depends on real supply-demand, while premium-liquor volume growth and series-liquor performance remain key areas for future validation.

Risks

• Premium baijiu volume growth below expectations.
• Moutai wholesale prices and retail prices continue to decline.
• Series-liquor performance remains weaker than expected despite resource allocation by the company.
• Non-Feitian Moutai SKUs may experience sales declines, putting pressure on product mix.
• Morgan Stanley disclosed potential or prospective business relationships with some covered companies; investors should treat this report as only one of several factors in investment decisions.

What to watch

• Transaction feedback from distributor and direct channels after the Feitian Moutai price increase.
• Whether wholesale prices remain stable after a short-term rebound.
• Continuous demand validation from the iMoutai platform.
• Sales and channel feedback after the price cuts to non-Feitian premium SKUs and Moutai 1935.
• The pace of premium baijiu consumption recovery.
• Whether the company will further increase direct-sales share or adjust distributor fee structures.